VITEK¿ 2 Systems Software Version 9.01 Update Kit.

FDA Device Recall #Z-0639-2019 — Class II — November 13, 2018

Recall Summary

Recall Number Z-0639-2019
Classification Class II — Moderate risk
Date Initiated November 13, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm bioMerieux, Inc.
Location Durham, NC
Product Type Devices
Quantity five (5) VITEK¿ 2 Systems Software version 9.01

Product Description

VITEK¿ 2 Systems Software Version 9.01 Update Kit.

Reason for Recall

The VITEK¿ 2 Systems Software Version 9.01 software may display incorrect organism identification information as well as the associated Antimicrobial Susceptibility Testing (AST) results when using the VITEK¿ 2 FLEXPREP" feature.

Distribution Pattern

Nationwide distribution to CO, IL, MO, TX.

Lot / Code Information

Product Description: KIT UPDT VTK2 9.01 EN, UDI: 03573026561260

Other Recalls from bioMerieux, Inc.

Recall # Classification Product Date
Z-2671-2025 Class II VITEK¿ 2 Gram-negative AST Test Kits (Cards) co... Jun 26, 2025
Z-1564-2022 Class II NUCLISENS easyMAG Magnetic Silica, REF 280133, ... Jul 20, 2022
Z-1640-2022 Class II VITEK 2 / MYLA VITEK 2 Software versions 8.0... Jul 13, 2022
Z-1059-2022 Class II VITEK 2 Systems and VITEK 2 with MYLA. Mar 29, 2022
Z-0742-2022 Class II VIDAS CMV IgM, 30 tests, REF 30205-01, IVD, Rx. Feb 9, 2022

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.